Elkem (ELK) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
18 Jan, 2026Executive summary
EBITDA reached NOK 1,235 million in Q3 2024, the highest since Q1 2023, driven by Silicones and operational improvements.
Total operating income was NOK 8,056 million, up 3% year-over-year, supported by Silicones division improvements and new China production line.
Silicones and Silicon Products divisions showed strong recovery, while Carbon Solutions remained resilient despite low sales volumes.
New bond loans of NOK 1,500 million were raised in September 2024, strengthening the financial position.
Sustainability efforts recognized with a Platinum EcoVadis rating and S&P Global 98th percentile; ongoing CO2 reduction projects received NOK 51 million in grants.
Financial highlights
Q3 2024 EBITDA up 131% year-over-year to NOK 1,235 million; EBITDA margin at 15% within target corridor.
Silicones division operating income up 20% year-over-year to NOK 3,843 million; EBITDA improved to NOK 202 million from a loss.
Silicon Products division EBITDA up 56% year-over-year to NOK 821 million, margin at 23%.
Carbon Solutions EBITDA down 14% year-over-year to NOK 269 million, but stable performance due to diversification.
EPS improved to NOK 0.15 in Q3 2024 and NOK 0.80 YTD; net profit for the period was NOK 117 million.
Outlook and guidance
Market sentiment remains weak, but cost and market positions are strong.
Silicones expected to benefit from improvement programs and higher sales volumes.
Silicon Products to see stable market conditions but lower realized sales prices.
Carbon Solutions to maintain stable performance leveraging strong market positions and diversification.
Overcapacity in silicones and silicon expected to persist, keeping price pressure.
Latest events from Elkem
- All agenda items, including the Bluestar share deal and capital decrease, were approved.ELK
EGM 20269 Mar 2026 - Silicones division sale to Bluestar and weak Q4 2025 results mark a major transformation.ELK
Q4 202513 Feb 2026 - EBITDA stable at NOK 1,030m; net profit up on tax assets, Silicones improved despite weak demand.ELK
Q2 20243 Feb 2026 - Strong financial performance and strategic investments drive sustainable growth.ELK
SEB Nordic Seminar presentation14 Jan 2026 - 2024 saw strong financials, strategic portfolio review, and top-tier ESG achievements.ELK
DNB Small & Medium Enterprises Conference presentation14 Jan 2026 - Stable results amid weak markets, with Silicones improving and strategic review ongoing.ELK
Lunch presentation14 Jan 2026 - Divesting Silicones to focus on core growth, backed by strong financials and global leadership.ELK
SEB Nordic Seminar presentation14 Jan 2026 - Q4 EBITDA up 84% YoY; Silicones under review and classified as discontinued operations.ELK
Q4 202423 Dec 2025 - EBITDA up 25% to NOK 898m as Silicones review advances amid market uncertainty.ELK
Q1 202528 Nov 2025